Target intelligence / Profile preview

Magnesium-adenosine triphosphate complex (Mg-ATP)

Target
Mg-ATP
Molecular classification
Cofactor, Metabolite, Nucleotide-metal complex, Other
01

Overview

Magnesium-adenosine triphosphate (Mg-ATP) is the physiologically active form of adenosine triphosphate within the cellular environment. Because the triphosphate chain of ATP carries multiple negative charges, it requires the coordination of a divalent cation, typically magnesium (Mg2+), to stabilize its structure and allow for efficient interaction with the binding pockets of enzymes [1]. This complex serves as the universal energy currency and a critical substrate for a vast array of enzymes, including kinases, ATPases, and DNA/RNA polymerases [2]. In these enzymatic reactions, the magnesium ion helps orient the ATP molecule and polarize the phosphate groups to facilitate nucleophilic attack during phosphoryl transfer [3]. While Mg-ATP itself is not typically the primary therapeutic target, it is the endogenous ligand that many small-molecule drugs, such as ATP-competitive kinase inhibitors, seek to displace to achieve therapeutic effects in diseases like cancer and inflammatory disorders [4]. Dysregulation of Mg-ATP levels or the Mg2+:ATP ratio is associated with various metabolic and mitochondrial pathologies, making its maintenance vital for cellular homeostasis [5]. Consequently, understanding the dynamics of this complex is essential for drug design, particularly in optimizing the binding affinity of inhibitors that must compete with high intracellular concentrations of Mg-ATP [6].

Other names
MgATPMagnesium ATPMg2+:ATPAdenosine 5'-triphosphate magnesium saltMagnesium adenosine 5'-triphosphate
02

Mechanism of action

Competitive inhibition of the ATP-binding site in kinases and ATPases; substrate for phosphoryl transfer reactions

03

Biological functions

Energy metabolismPhosphorylationSignal transductionActive transportMuscle contractionOther
04

Disease associations

Mitochondrial diseaseMetabolic syndromeHypomagnesemiaIschemic heart diseaseCancerOther
05

Safety considerations

Electrolyte imbalanceOff-target kinase inhibitionMetabolic toxicityHypermagnesemia
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

Intracellular free magnesium concentrationATP/ADP ratio31P-NMR chemical shift of ATP phosphatesSerum magnesium levels

Beyond the preview

Go deeper on Magnesium-adenosine triphosphate complex (Mg-ATP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magnesium-adenosine triphosphate complex (Mg-ATP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call